Candidate genetic variants included in a genetic risk algorithm may not meet standards of reasonable clinical efficacy in identifying opioid use disorder risk, according to a study published in JAMA ...

The US Food and Drug Administration (FDA) has approved Journavx, a new pain reliever without the risks of addiction or overdose linked to drugs like Vicodin and OxyContin.

Dr. Sanjay Gupta said Tuesday that the approval of a new non-opioid pain medication is “a pretty big deal.” “This is a pretty big deal,” Gupta said. “As you just mentioned, it’s been since 1998 that ...

Federal officials have approved a new type of pain pill designed to eliminate the risks of addiction and overdose associated with opioid medications like Vicodin and OxyContin. The U.S.

GLP-1 drugs mimic a hormone that sends the brain signals of fullness. Researchers theorize that the drugs could work the same ...

A new painkiller that is said to be free of addiction risks may be transformative for treatment of acute pain, according to ...

New research suggests that Ozempic and similar weight loss medications have the potential to be as big a game changer in ...

Introducing Journavx: the FDA-approved non-opioid, non-addictive drug for acute pain. A major breakthrough in pain medication ...

A new opioid-free pain medication was approved by the FDA on Thursday, marking a non-addictive alternative for patients.

Will people with acute pain want a new painkiller whose list price is $15.50 a pill when a generic prescription drug is at ...

This new nonaddictive alternative is the first of its kind that interrupts the pain signal before it reaches the brain.

The FDA just approved a new type of pain medication, and it's a non-opioid called suzetrigine that stops body pain at its ...